Success Story: Research Fellow in Biotechnology Achieves NIW Approval for Gene-Editing Innovation

Posted by wegreened on August 17, 2026 in NIW, Biotechnology

Client’s Testimonial:

"Thank you so much for your time and effort. I very much appreciate that!”

On June 25^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Research Fellow

Country of Origin: Taiwan

State of Residence at the Time of Filing: Michigan

Approval Notice Date: June 25^th, 2026

Processing Time: 4 months, 13 days (Premium Processing Requested)

Case Summary:

The client, a research fellow at the time of filing, proposed to continue advancing gene-editing technologies to uncover gene regulatory mechanisms underlying disease pathogenesis. The petition emphasized the broader significance of this work in improving the understanding of immune dysfunction and cardiovascular disease while supporting the development of targeted therapeutic strategies. North America Immigration Law Group (Chen Immigration Law Associates) structured the case around the national importance of genome engineering research in accelerating biomedical innovation and precision medicine.

A central component of this work involved leveraging cutting-edge genomic platforms and advanced research models to investigate the genetic foundations of human illness. The focus centered on improving the efficiency and precision of genetic modifications while engineering sophisticated models to map disease pathways with higher fidelity. Ultimately, these innovations drove the discovery of novel therapeutics for prevalent, difficult-to-treat disorders, directly supporting broader clinical innovation.

The client’s academic and research background demonstrated strong preparation for this work. Holding a Ph.D. in biotechnology, the client has developed technical expertise in gene editing, embryology, micromanipulation, cell culture, and molecular biology. The record included 11 peer-reviewed journal articles, 4 first-authored abstracts, and 1 preprint, published in respected journals.

The petition further highlighted the impact of the client’s research within the scientific community. The client’s work had received 81 citations, including multiple publications ranked among the top 20% most-cited articles in Molecular Biology & Genetics. Other researchers have built upon the client’s findings in studies involving genome stability, metabolic regulation during development, stem cell DNA repair mechanisms, and translational applications of gene-editing technologies. The client also completed at least 2 peer reviews for journals in cell and developmental biology, reflecting recognition by the scientific community.

USCIS approved the NIW petition on June 25th, 2026, following a Premium Processing upgrade on May 5th, 2026. With strategic case preparation handled by NAILG, this approval reflected the strength of a case centered on cutting-edge genome editing research with clear relevance to human health and biomedical innovation.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%